Literature DB >> 2996416

Detection of picornavirus sequences in nervous tissue of amyotrophic lateral sclerosis and control patients.

M Brahic, R A Smith, C J Gibbs, R M Garruto, W W Tourtellotte, E Cash.   

Abstract

We used in situ hybridization to look for picornavirus ribonucleic acid (RNA) sequences in frozen sections of central nervous system (CNS) tissue of amyotrophic lateral sclerosis (ALS) and control patients. Using reconstruction experiments, we concluded that 30 copies of viral RNA per cell could be detected with the assay. RNA which hybridized to DNAs complementary (cDNAs) to both poliovirus and Theiler's virus was found at several levels in the CNS of 2 patients, 1 ALS patient, and 1 control. In transverse sections of the spinal cord, these sequences predominated in cells of the anterior horns. We assessed the specificity of hybridization by several criteria: no hybridization was observed with heterologous visna virus cDNA probes; hybridization was abolished by pretreatment of the sections with ribonuclease; chemography artifacts were ruled out; and the results were reproduced in three independent experiments. We concluded that RNA molecules, possibly belonging to a picornavirus having sequences in common with poliovirus and Theiler's virus, were present in the CNS of these 2 patients. On the other hand, 14 cases of classic ALS, 2 cases of Guamanian parkinsonian dementia, and 5 controls had negative results. However, the presence of picornavirus sequences in our series could be underestimated because in many cases autolysis times were 10 hours or longer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996416     DOI: 10.1002/ana.410180311

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  The widening spectrum of infectious neurological disease.

Authors:  P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

2.  Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

3.  Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals.

Authors:  O D Uchitel; S H Appel; F Crawford; L Sczcupak
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state.

Authors:  Mikael J Lindberg; Lena Tibell; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 5.  Poliovirus and motor neuron disease.

Authors:  C N Martyn
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

6.  Quest for a reliable, valid, and sensitive in situ hybridization procedure to detect viral nucleic acids in the central nervous system.

Authors:  W W Tourtellotte; P Schmid; P Pick; N Verity; S Martinez; P Shapshak
Journal:  Neurochem Res       Date:  1987-06       Impact factor: 3.996

7.  DNA probes for clinical applications. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-06       Impact factor: 2.926

8.  The environment in childhood and risk of motor neuron disease.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

9.  Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease.

Authors:  C J Woodall; M H Riding; D I Graham; G B Clements
Journal:  BMJ       Date:  1994-06-11

10.  Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis.

Authors:  H Ito; A Hirano
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.